Min-Ting Lin

563 total citations
8 papers, 448 citations indexed

About

Min-Ting Lin is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Min-Ting Lin has authored 8 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Pharmacology and 2 papers in Oncology. Recurrent topics in Min-Ting Lin's work include Cell death mechanisms and regulation (2 papers), Microbial Natural Products and Biosynthesis (2 papers) and Bioactive Natural Diterpenoids Research (2 papers). Min-Ting Lin is often cited by papers focused on Cell death mechanisms and regulation (2 papers), Microbial Natural Products and Biosynthesis (2 papers) and Bioactive Natural Diterpenoids Research (2 papers). Min-Ting Lin collaborates with scholars based in China and Hong Kong. Min-Ting Lin's co-authors include Jianye Zhang, Hubiao Chen, Yina Tang, Tao Yi, Zhongzhen Zhao, Wenjing Huang, Yanyan Yan, Jinxiang Ma, Hong Bi and Zhijun Yang and has published in prestigious journals such as Molecules, Signal Transduction and Targeted Therapy and Oncotarget.

In The Last Decade

Min-Ting Lin

8 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Min-Ting Lin China 8 301 147 65 51 48 8 448
Yi‐Ting Hsi Taiwan 13 283 0.9× 118 0.8× 70 1.1× 32 0.6× 50 1.0× 15 480
Liuning Li China 12 286 1.0× 125 0.9× 74 1.1× 27 0.5× 68 1.4× 23 427
Noor Hasima Malaysia 8 283 0.9× 84 0.6× 59 0.9× 90 1.8× 50 1.0× 9 512
Yung-Ting Hsiao Taiwan 14 244 0.8× 70 0.5× 42 0.6× 39 0.8× 48 1.0× 15 387
Ying Zan China 12 403 1.3× 239 1.6× 81 1.2× 23 0.5× 80 1.7× 21 640
Wengang Wang China 6 205 0.7× 81 0.6× 45 0.7× 28 0.5× 46 1.0× 7 363
Nidarshana Chaturvedi Parashar India 13 335 1.1× 69 0.5× 87 1.3× 31 0.6× 52 1.1× 23 552
Guoguo Jin China 14 350 1.2× 131 0.9× 50 0.8× 44 0.9× 142 3.0× 25 643
Ritu Raina Saudi Arabia 10 221 0.7× 56 0.4× 60 0.9× 32 0.6× 39 0.8× 15 373
Jeong‐Geon Mun South Korea 14 251 0.8× 80 0.5× 52 0.8× 18 0.4× 76 1.6× 19 434

Countries citing papers authored by Min-Ting Lin

Since Specialization
Citations

This map shows the geographic impact of Min-Ting Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min-Ting Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min-Ting Lin more than expected).

Fields of papers citing papers by Min-Ting Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min-Ting Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min-Ting Lin. The network helps show where Min-Ting Lin may publish in the future.

Co-authorship network of co-authors of Min-Ting Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Min-Ting Lin. A scholar is included among the top collaborators of Min-Ting Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min-Ting Lin. Min-Ting Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Huang, Wenjing, Yanyan Yan, Yun Liu, et al.. (2020). Exosomes with low miR-34c-3p expression promote invasion and migration of non-small cell lung cancer by upregulating integrin α2β1. Signal Transduction and Targeted Therapy. 5(1). 39–39. 105 indexed citations
2.
Zhang, Jianye, et al.. (2017). Apicidin Inhibited Proliferation and Invasion and Induced Apoptosis via Mitochondrial Pathway in Non-small Cell Lung Cancer GLC-82 Cells. Anti-Cancer Agents in Medicinal Chemistry. 17(10). 1374–1382. 14 indexed citations
3.
Lin, Min-Ting, Hong Bi, Yanyan Yan, et al.. (2017). Parthenolide suppresses non-small cell lung cancer GLC-82 cells growth via B-Raf/MAPK/Erk pathway. Oncotarget. 8(14). 23436–23447. 59 indexed citations
4.
Lin, Min-Ting, Chao Zhang, Hubiao Chen, et al.. (2016). Euphorbia factor L2 induces apoptosis in A549 cells through the mitochondrial pathway. Acta Pharmaceutica Sinica B. 7(1). 59–64. 50 indexed citations
5.
Zhang, Jianye, Min-Ting Lin, Tao Yi, et al.. (2016). Bruceine D induces apoptosis in human chronic myeloid leukemia K562 cells via mitochondrial pathway.. PubMed. 6(4). 819–26. 47 indexed citations
6.
Tao, Yiwen, et al.. (2015). Anticancer Activity and Mechanism Investigation of Beauvericin Isolated from Secondary Metabolites of the Mangrove Endophytic Fungi. Anti-Cancer Agents in Medicinal Chemistry. 15(2). 258–266. 49 indexed citations
7.
Zhang, Jianye, Min-Ting Lin, Tao Yi, et al.. (2015). Combinational Treatment of Curcumin and Quercetin against Gastric Cancer MGC-803 Cells in Vitro. Molecules. 20(6). 11524–11534. 98 indexed citations
8.
Zhang, Jianye, Min-Ting Lin, Tao Yi, et al.. (2013). Apoptosis Sensitization by Euphorbia Factor L1 in ABCB1-Mediated Multidrug Resistant K562/ADR Cells. Molecules. 18(10). 12793–12808. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026